95329 ⎘
Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine
A TRIFLUOROMETHYL THIANTHRENIUM COMPOUND, PROCESS FOR PREPARING THE SAME AND THE USE THEREOF
#2FUNCTIONALIZED FLUOROALKYL SILANE, AND SYNTHETIC METHOD THEREFOR AND APPLICATION THEREOF
#3METHODS FOR EXTRACTION, PROCESSING, AND PURIFICATION OF A SELECTED FAMILY OF TARGET COMPOUNDS FROM CANNABIS
#4Synthetic dimeric cinchona alkaloids against cancer
#5Methods for extraction, processing, and purification of a selected family of target compounds from cannabis
#6Methods for extraction, processing, and purification of a selected family of target compounds from cannabis
#7Process for the preparation of isoxazoline compounds
#8Cinchonium betaine catalysts and methods of using same
#9Cinchonine-derived catalysts and methods of using same
#10Chiral phase-transfer catalyst and method for preparing alpha-amino acid by using the same
#11Process for the preparation of isoxazoline compounds
#12Cinchonium betaine catalysts and methods of using same
#13Amides of acetic and propionic acids
#14Compounds as anti-tubercular agents
#15Process for the preparation of isoxazoline compounds
#16Process for the preparation of optically active isoxazoline compounds
#17Superficially porous particle (SPP) chiral phases for liquid chromatography
#18Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity
#19Substituted imidazoquinolines
#20Catalysts and related processes for producing optically pure beta-lactones from aldehydes and compositions produced thereby
#21Picolinamide-cinchona organocatalysts and derivatives
#22Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity
#232′, 3′-dideoxy-5-fluorouridine derivatives, a process for the manufacture thereof and application thereof
#24Amides of acetic and propionic acids
#25Cyclohexyl and quinuclidinyl carbamate derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activity
#26Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv
#27Kinetic resolution
#28Bis-quaternary cinchona alkaloid salts as asymmetric phase transfer catalysts
#29Method for catalytic asymmetric synthesis of optically active isoxazoline compound and optically active isoxazoline compound
#30Process for the preparation of gamma amino acids and intermediates used in said process
#31Processes for the preparation of pyrrolidine intermediates
#32Conjugate addition reactions using bifunctional cinchona-alkaloid-based catalysts
#33Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV
#34Amides of acetic and propionic acids
#35Enantioselective organic anhydride reactions
#36Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
#37Kinetic resolution
#38Nuclear Hormone Receptor Modulators
#39Catalysts and related processes for producing optically pure beta-lactones from aldehydes and compositions produced thereby
#40Process for the preparation of cis-2-methylspiro (1,3-oxathiolane 5-3′) quinuclidine
#41Conjugate addition reactions using bifunctional -alkaloid-based catalysts
#42Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV
#43Method for the production of 1,4-benzothiepin-1,1-dioxide derivatives
#44Substituted imidazoquinolines
#45Cinchona-based bifucntional organocatalysts and method for preparing chiral hemiesters using the same
#46Pyrazole compounds and uses thereof
#47Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
#48Metal-Catalyzed Carbon-Fluorine Bond Formation
#49Therapeutic compounds
#50Amides of acetic and propionic acids
#51Quinine Sulfate Polymorphs, Processes of Preparing, Compositions and Uses Thereof
#52Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
#53Nicotinic acetylcholine receptor modulators
#54Method of Preparing Amine Stereoisomers
#55Macrocyclic benzofused pyrimidine derivatives
#56Amine Salts Of (-)-2-((2-(4-Hydroxyphenyl)Ethyl)Thio)-3-(4-(2-(4-((Methylsulfonyl)Oxy)Phenoxy)Ethyl)Phenyl) Propanoic Acid
#57Pyrazole compounds and uses thereof
#58Sulfamoyl sulfonate prodrugs
#59Asymmetric aldol additions using bifunctional cinchona-alkaloid-based catalysts
#60Asymmetric carbon-carbon-bond-forming reactions catalyzed by bifunctional cinchona alkaloids
#61Amides of acetic and propionic acids
#62Method of preparing amine stereoisomers
#63Agents useful for reducing amylioid precursor protein and treating dementia and methods of use thereof
#64Cephalotaxane derivatives and their processes of preparation and purification
#65Asymmetric Michael and Aldol additions using bifunctional cinchona-alkaloid-based catalysts
#66Method of preparing amine stereoisomers
#67Optically active compounds, method for kinetic optical resolution of carboxylic acid derivatives and catalysts therefor
#68Pleuromutilin derivatives with antimicrobial activity
#69Cephalotaxane derivatives and their processes of preparation and purification
#70Cinchona-alkaloid-based catalysts, and asymmetric alcoholysis of cyclic anhydrides using them